Irreversible protein kinase inhibitors: balancing the benefits and risks

  • J Med Chem. 2012 Jul 26;55(14):6243-62. doi: 10.1021/jm3003203.
Tjeerd Barf  1 ,  Allard Kaptein
Affiliations
  • 1. Drug Discovery Unit, Covalution Pharma BV, Ravenstein, The Netherlands. [email protected]
PMID: 22621397 DOI: 10.1021/jm3003203